Answers are grounded in this paper and cite their sources.
Background: Objective fluid assessment in hemodialysis often requires dedicated bioimpedance equipment. The Laboratory-Data Integrated Fluid Targeting algorithm uses routine biochemical and dialysis treatment data to estimate extracellular water, intracellular water, and euvolemic body weight. We evaluated its concordance with the Fresenius Body Composition Monitor and explored determinants of method differences. Methods: In this prospective single-center study, 61 adults receiving stable maintenance hemodialysis for at least 3 months underwent paired assessment during one dialysis session. Agreement was evaluated using Pearson correlation, Deming regression, and Bland–Altman analysis. Exploratory multivariable models were used to examine age, sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease. Clinically prescribed dry weight was analyzed as a separate clinical comparator. Results: Extracellular-water estimates were strongly correlated (correlation coefficient, 0.87). The mean difference between the Laboratory-Data Integrated Fluid Targeting and Body Composition Monitor estimates was +0.22 L, with 95% limits of agreement from −4.1 to +4.6 L. The correlation for intracellular water was lower (correlation coefficient, 0.80), with a mean difference of +2.7 L and limits of agreement from −3.5 to +8.9 L. Estimated euvolemic weight was strongly correlated (correlation coefficient, 1.0 after rounding), although this partly reflected the shared body-weight component (mean difference, −0.67 kg; limits of agreement, −4.0 to +2.6 kg). Older age was associated with a smaller extracellular-water difference, whereas sex, dialysis vintage, diabetes, heart failure, and ischemic heart disease were not independently associated with method differences. Conclusions: The laboratory-based algorithm approximated Body Composition Monitor outputs at the cohort level; however, proportional bias and wide individual limits, particularly for intracellular water, preclude interchangeability. These findings support method concordance but do not constitute independent physiological or outcome validation. Clinical actionability and outcome benefit remain untested.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: